|
Volumn 23, Issue 6, 2000, Pages 593-598
|
Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin
a,b,c a,b,c a,b,c a,b,c a,b,c |
Author keywords
Gadolinium; Radiation therapy; Radiosensitizers; Renal toxicity; Texaphyrin
|
Indexed keywords
GADOLINIUM TEXAPHYRIN;
NSC 695238;
RADIOSENSITIZING AGENT;
ADULT;
ARTICLE;
CANCER;
CANCER RADIOTHERAPY;
CASE REPORT;
CLINICAL TRIAL;
DOSE RESPONSE;
FEMALE;
HUMAN;
IMAGE ENHANCEMENT;
KIDNEY FAILURE;
MALE;
METASTASIS;
NEPHROTOXICITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHASE 1 CLINICAL TRIAL;
ADULT;
BIOLOGICAL MARKERS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
GADOLINIUM;
HUMANS;
KIDNEY DISEASES;
MALE;
METALLOPORPHYRINS;
MIDDLE AGED;
NEOPLASMS;
PALLIATIVE CARE;
RADIATION-SENSITIZING AGENTS;
|
EID: 0034443675
PISSN: 02773732
EISSN: None
Source Type: Journal
DOI: 10.1097/00000421-200012000-00013 Document Type: Article |
Times cited : (16)
|
References (13)
|